Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-κB and NF-IL6 in cardiac myocytes

Cardiovascular Research

Volumn 42, Issue 1, 1999, Pages 104-112

  Matsui, Hideo ^a   Ihara, Yoshiji ^a   Fujio, Yasushi ^a   Kunisada, Keita ^a   Akira, Sizuo ^b   Kishimoto, Tadamitsu ^a   Yamauchi Takihara, Keiko ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Cardiac myocytes; Gene expression; Hypoxia; Interleukin 6; Nuclear factor B; Rat

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LUCIFERASE;

ANIMAL CELL; ARTICLE; BINDING SITE; ENZYME ACTIVITY; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; HEART MUSCLE CELL; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; RAT; TRANSCRIPTION REGULATION;

ANIMALS; ANOXIA; BINDING SITES; BLOTTING, NORTHERN; CCAAT-ENHANCER-BINDING PROTEINS; CELLS, CULTURED; DNA-BINDING PROTEINS; ELECTROPHORESIS; GENE EXPRESSION REGULATION; INTERLEUKIN-6; LUCIFERASES; MYOCARDIUM; NF-KAPPA B; NUCLEAR PROTEINS; PLASMIDS; RATS; TRANSFECTION;

EID: 0032920658     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00285-5     Document Type: Article

References (35)

1. Yamauchi-Takihara K., Ihara Y., Ogata A.et al. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation. 91:1995;1520-1524.
2. Webster K.A., Discher D.J., Bishopric N.H. Induction and nuclear accumulation of fos and jun proto-oncogenes in hypoxic cardiac myocytes. J Biol Chem. 268:1993;16852-16858.
3. Yan S.F., Tritto I., Pinsky D.et al. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells: Central role of the binding site for nuclear factor-IL-6. J Biol Chem. 270:1995;11463-11471.
4. Karakurum M., Shreeniwas R., Chen J.et al. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest. 93:1994;1564-1570.
5. Kohase M., May L.T., Tamm I., Vilcek J., Sehgal P.B. A cytokine network in human diploid fibroblasts: interactions of β-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1. Mol Cell Biol. 7:1987;273-280.
6. Loppnow H., Libby P. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J Clin Invest. 85:1990;731-738.
7. Matsumori A., Shioi T., Yamada T., Matsui S., Sasayama S. Vesnarinone, a new inotrophic agent, inhibits cytokine production by stimulated human blood from patients with heart failure. Circulation. 89:1994;955-958.
8. Miyao Y., Yasue H., Ogawa H.et al. Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J. 126:1993;1299-1304.
9. Barton B.E., Jackson J.V. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model. Infect Immun. 61:1993;1496-1499.
10. Kanda T., McManus J.E.W., Nagai R.et al. Modification of viral myocarditis in mice by interleukin-6. Circ Res. 78:1996;848-856.
11. Isshiki H., Akira S., Tanabe O.et al. Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene. Mol Cell Biol. 10:1990;2757-2764.
12. Akira S., Isshiki H., Sugita T.et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9:1990;1897-1906.
13. Matsusaka T., Fujikawa K., Nishio Y.et al. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA. 90:1993;10193-10197.
14. Lenardo M.J., Baltimore D. NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control. Cell. 58:1989;227-229.
15. Morishita R., Sugimoto T., Aoki M.et al. In vivo transfection of cis element 'decoy' against nuclear factor κB binding site prevents myocardial infarction. Nat Med. 3:1997;894-899.
16. Mukaida N., Mahe Y., Matsushima K. Cooperative interaction of nuclear factor-κB- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem. 265:1990;21128-21133.
17. Brasier A.R., Li J., Copland A. Transcription factors modulating angiotensinogen gene expression in hepatocytes. Kidney Int. 46:1994;1564-1566.
18. Collins T., Read M.A., Neish A.S.et al. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 9:1995;899-909.
19. Dunn S.M., Coles L.S., Lang R.K., Gerondakis S., Vadas M.A., Shannon M.F. Requirement for nuclear factor(NF)-κB p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter. Blood. 83:1994;2469-2479.
20. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
21. Tanabe O., Akira S., Kamiya T.et al. Genomic structure of the murine IL-6 gene: high degree conservation of potential regulatory sequences between mouse and human. J Immunol. 141:1988;3875-3881.
22. Fujio Y., Kunisada K., Hirota H., Yamauchi-Takihara K., Kishimoto T. Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. J Clin Invest. 99:1997;2898-2905.
23. Nishio Y., Isshiki H., Kishimoto T., Akira S. A nuclear factor for interleukin-6 expression (NF-IL6) and the glucocorticoid receptor synergistically activate transcription of the rat α1-acid glycoprotein gene via direct protein-protein interaction. Mol Cell Biol. 13:1993;1854-1862.
24. Balligand J.L., Ungureanu D., Kelly R.A.et al. Abnormal contractile function due to induction on nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest. 91:1993;2314-2319.
25. Palmer J.N., Hartogensis W.E., Patten M., Fortuin F.D., Long C.S. Interleukin-1β induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J Clin Invest. 95:1995;2555-2564.
26. Ohkawa F., Ikeda U., Kawasaki K.et al. Inhibitory effect of interleukin-6 on vascular smooth muscle contraction. Am J Physiol. 266:1994;H898-H902.
27. Yan S.F., Zou Y.S., Mendelsohn M.et al. Nuclear factor interleukin 6 motifs mediate tissue-specific gene transcription in hypoxia. J Biol Chem. 272:1997;4287-4294.
28. Takeuchi M., Rothe M., Goeddel D.V. Anatomy of TRAF2: Distinct domains for nuclear factor-κB activation and association with tumor necrosis factor signaling proteins. J Biol Chem. 271:1996;19935-19942.
29. Cao Z., Xiong J., Takeuchi M., Kurama T., Goeddel D.V. TRAF6 is a signal transducer for interleukin-1. Nature. 383:1996;443-446.
30. Koong A.C., Chen E.Y., Mivechi N.F.et al. Hypoxic activation of nuclear factor-κB is mediated by a Ras and Raf signaling pathway and does not involved MAP kinase (ERK1 or ERK2). Cancer Res. 54:1994;5273-5279.
31. Levy A.P., Levy N.S., Loscalzo J.et al. Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res. 76:1995;758-766.
32. Seko Y., Tobe K., Ueki K., Kadowaki T., Yazaki Y. Hypoxia and hypoxia/reoxygenation activate Raf-1, mitogen-activated protein kinase kinase, mitogen-activated protein kinase, and S6 kinase in cultured cardiac myocytes. Circ Res. 78:1996;82-90.
33. Seko Y., Tobe K., Takahashi N.et al. Hypoxia and hypoxia/reoxygenation activate Src family tyrosine kinase and p21ras in cultured cardiac myocytes. Biochem Biophys Res Commun. 226:1996;530-535.
34. Bodi I., Bishopric N.H., Discher D.J., Wu X., Webster K.A. Cell-specificity and signaling pathway of endothelin-1 gene regulation by hypoxia. Cardiovasc Res. 30:1995;975-984.
35. Xing Z., Gauldie J., Cox G.et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest. 101:1998;311-320.